Accuray reported $292.39M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 357.52M 566K Mar/2026
AtriCure USD 313.69M 8.82M Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 887.1M 268.96M Mar/2026
Trinity Biotech USD 35.52M 2.52M Sep/2025